Skip to content
Trial Eligibility
Menu

Cannabidiol and Older Adult Cannabis Users

NCT06290063

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Cannabis use increased 10 fold among adults over the age of 65 between 2014 and 2016 but very little data exists on the extent of their harmful effects on health and behavior. The overarching goal of this project is to test a novel harm reduction strategy in which older individuals who seek to use cannabis for pain, anxiety or mood problems (depression/anxiety) will be randomly assigned to one of three conditions in an 8 week randomized controlled trial: hemp-derived CBD+THC, hemp-derived CBD-THC, or placebo.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Sleep
  • Anxiety
  • Depression
  • Pain

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
60 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Colorado, Boulder
Last updated on ClinicalTrials.gov
June 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • University of Colorado at Boulder · Boulder, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.